Walder Wyss advised Adjuvant Capital. Memo Therapeutics AG, an innovator in the field of antibody discovery and development, announced the close of an oversubscribed Series B...
Walder Wyss advised Adjuvant Capital. Memo Therapeutics AG, an innovator in the field of antibody discovery and development, announced the close of an oversubscribed Series B...
You must be a Standard 1 Year member to access this content.